Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism S1PR1 agonists(Sphingosine 1-phosphate receptor Edg-1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H28N2O6S |
InChIKeyGBHBXUPRNNLGHG-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bradycardia | Preclinical | KR | 25 Jul 2023 | |
Multiple Sclerosis | Preclinical | KR | 25 Jul 2023 |